Assessment of Abnormal Liver Function Tests in Dengue Fever: Implications for Disease Severity and Outcome

Authors

  • Muhammad Jamil Nishtar Hospital, Multan, Punjab, Pakistan.
  • Taimoor Ahmed Nishtar Hospital, Multan, Punjab, Pakistan.
  • Muhammad Mohaymin Ali Nishtar Hospital, Multan, Punjab, Pakistan.
  • Hafiz Junaid Javed Mukhtar A. Sheikh Hospital, Multan, Punjab, Pakistan.
  • Ayesha Waheed Bakhtwar Amin Hospital, Multan, Punjab, Pakistan.
  • Adeel Ahmed Nishtar Hospital, Multan, Punjab, Pakistan.
  • Muhammad Irfan Jamil Lahore General Hospital, Lahore, Punjab, Pakistan.

DOI:

https://doi.org/10.70749/ijbr.v3i4.779

Keywords:

Dengue, Liver Function Tests, Hepatomegaly, Hemorrhagic Manifestations, Mortality

Abstract

Background and Objective: Dengue fever, a significant tropical disease, often presents with liver dysfunction. This study evaluated the association between elevated liver function tests (AST, ALT, bilirubin) and clinical outcomes and mortality, to identify prognostic indicators. Material & Methods: This cross-sectional study was conducted in the department of Medicine, Nishtar Hospital, Multan, over a 15-month period from July 2024 to September 2024. Patients with confirmed dengue fever were enrolled using a non-probability consecutive sampling technique. Statistical analysis was performed using SPSS version 26.0. Results: A total of 146 patients were included, with a mean age of 48 ± 17 years; the most common age group was 31 to 45 years (32%). Males constituted 78 (53%) of the sample. Dengue fever (DF) was identified in 85 (58%), dengue hemorrhagic fever (DHF) in 37 (25%) and dengue shock syndrome (DSS) in 24 (16%). AST and ALT levels were significantly elevated in DSS (670.4 ± 701.5 U/L and 700.8 ± 750.3 U/L) compared to DHF (550.7 ± 660.3 U/L and 560.4 ± 720.8 U/L) and DF (482.8 ± 645.6 U/L and 496.1 ± 683.1 U/L) (p < 0.001). Mortality was 38% in DSS and 11% in DHF (p<0.001). AST, ALT, and bilirubin were significantly higher in non-survivors (p<0.001). Severe liver dysfunction (AST + ALT > 300 U/L) was associated with increased mortality. Conclusion: This study highlights the strong association of elevated LFTs with severe dengue outcomes, underscoring their prognostic value in assessing severity and guiding interventions.

Downloads

Download data is not yet available.

References

Li, H., Su, M. P., Wu, S., Tsou, H., Chang, M., Cheng, Y., Tsai, K., Wang, H., Chen, G., Tang, C., Chung, P., Tsai, W., Huang, L., Yueh, Y. A., Chen, H., Pan, C., Akbari, O. S., Chang, H., Yu, G., … Chen, C. (2023). Mechanical transmission of dengue virus by aedes aegypti may influence disease transmission dynamics during outbreaks. eBioMedicine, 94, 104723. https://doi.org/10.1016/j.ebiom.2023.104723

Khanam, A., Gutiérrez-Barbosa, H., Lyke, K. E., & Chua, J. V. (2022). Immune-mediated pathogenesis in dengue virus infection. Viruses, 14(11), 2575. https://doi.org/10.3390/v14112575

Khan, M. B., Yang, Z., Lin, C., Hsu, M., Urbina, A. N., Assavalapsakul, W., Wang, W., Chen, Y., & Wang, S. (2023). Dengue overview: An updated systemic review. Journal of Infection and Public Health, 16(10), 1625-1642. https://doi.org/10.1016/j.jiph.2023.08.001

Zohra, T., Din, M., Ikram, A., Bashir, A., Jahangir, H., Baloch, I. S., Irshad, S., Waris, A., Salman, M., Iqtadar, S., & Ayaz, M. (2024). Demographic and clinical features of dengue fever infection in Pakistan: A cross-sectional epidemiological study. Tropical Diseases, Travel Medicine and Vaccines, 10(1). https://doi.org/10.1186/s40794-024-00221-4

Shankar, R. B., Chakravarthy, B. S., Pilli, S., Raju, M. S., Naik, K. S., & Lagudu, R. N. (2024). LIVER ENZYMES AS AN EARLY PREDICTOR OF SEVERE DENGUE FEVER. Int J Acad Med Pharm, 6(1), 333-336. https://academicmed.org/Uploads/Volume6Issue1/65.%20[2224.%20JAMP_Jafar]%20333-336.pdf

Weng, W., Chen, J., Peng, X., Huang, M., Zhang, J., Xiong, J., Cao, H., & Lin, B. (2022). Risk factors for underlying comorbidities and complications in patients with hepatitis B virus-related acute-on-chronic liver failure. Epidemiology and Infection, 150. https://doi.org/10.1017/s0950268822001169

Nasir, M., Irfan, J., Asif, A. B., Khan, Q. U., & Anwar, H. (2024). Complexities of dengue fever: Pathogenesis, clinical features and management strategies. Discoveries, 12(2), e189. https://doi.org/10.15190/d.2024.8

Leowattana, W., & Leowattana, T. (2021). Dengue hemorrhagic fever and the liver. World Journal of Hepatology, 13(12), 1968-1976. https://doi.org/10.4254/wjh.v13.i12.1968

Campana, V., Inizan, C., Pommier, J., Menudier, L. Y., Vincent, M., Lecuit, M., Lamballerie, X. D., Dupont‐Rouzeyrol, M., Murgue, B., & Cabié, A. (2024). Liver involvement in dengue: A systematic review. Reviews in Medical Virology, 34(4). https://doi.org/10.1002/rmv.2564

Saghir, H., Tariq, M., Safdar, N., Zahoor, A., Rashid, F., Khan, S. E., Abid, S., & Mumtaz, H. (2023). Association of liver function test with severity of dengue fever in suburbs of Islamabad. Journal of Community Hospital Internal Medicine Perspectives, 13(6). https://doi.org/10.55729/2000-9666.1250

Gupta, Dr. R. S. (2019). ASSESSMENT OF LIVER FUNCTION TESTS IN DENGUE FEVER. International Journal of Medical and Biomedical Studies, 3(8). https://doi.org/10.32553/ijmbs.v3i8.437

Dhotre, P. S., Sanakal, D. B., Dhotre, S. V., Patil, R. S., & BS, N. (2022). Evaluation of alterations in liver function tests in dengue fever. Res. Med. J, 7. https://www.resclinmed.eu/public/data_files/articles/153/article_153.pdf

Das, S., Abreu, C., Harris, M., Shrader, J., & Sarvepalli, S. (2022). Severe Thrombocytopenia associated with dengue fever: An evidence-based approach to management of Thrombocytopenia. Case Reports in Hematology, 2022, 1-3. https://doi.org/10.1155/2022/3358325

Yang, M., Lin, C., Chen, Y., Lu, I., Su, B., Chen, Y., Liu, K., Wu, C., & Shiau, A. (2024). Prothymosin α accelerates dengue virus-induced thrombocytopenia. iScience, 27(1), 108422. https://doi.org/10.1016/j.isci.2023.108422

Casenghi, M., Kosack, C., Li, R., Bastard, M., & Ford, N. (2018). NS1 antigen detecting assays for diagnosing acute dengue infection in people living in or returning from endemic countries. Cochrane Database of Systematic Reviews. https://doi.org/10.1002/14651858.cd011155.pub2

Singh, R. K., Tiwari, A., Satone, P. D., Priya, T., & Meshram, R. J. (2023). Updates in the management of dengue shock syndrome: A comprehensive review. Cureus. https://doi.org/10.7759/cureus.46713

Ahmad, W., Younas, M., Kashif, M., Sajjad, M., Ali, M., & Ramzan, S. (2024). Elevated liver enzymes in dengue fever: implications for disease severity. Gomal Journal of Medical Sciences, 22(1), 32-36. https://www.gjms.com.pk/index.php/journal/article/view/1454

Kittitrakul, C., Silachamroon, U., Phumratanaprapin, W., Krudsood, S., Wilairatana, P., & Treeprasertsuk, S. (2015). Liver function tests abnormality and clinical severity of dengue infection in adult patients. J Med Assoc Thai, 98(Suppl 1), S1-8. https://www.thaiscience.info/Journals/Article/JMAT/10971027.pdf

Ahmed, A., Alvi, A. H., Butt, A., Nawaz, A. A., & Hanif, A. (2014). Assessment of dengue fever severity through liver function tests. J Coll Physicians Surg Pak, 24(9), 640-644. https://www.jcpsp.pk/archive/2014/Sep2014/08.pdf

Swamy, A. M., Mahesh, P. Y., & Tumkur, S. R. (2021). Liver function in dengue and it's correlation with disease severity: An retrospective cross-sectional observational study in a tertiary care center in coastal India. Pan African Medical Journal, 40. https://doi.org/10.11604/pamj.2021.40.261.29795

Ravilla, S., Padmaprakash, K. V., Arun, N., & Kanth, R. (2022). Liver function test abnormalities: Do they correlate with severity in dengue infection? An Indian perspective. Journal of Marine Medical Society, 25(1), 48-52. https://doi.org/10.4103/jmms.jmms_88_22

Downloads

Published

2025-04-13

How to Cite

Assessment of Abnormal Liver Function Tests in Dengue Fever: Implications for Disease Severity and Outcome. (2025). Indus Journal of Bioscience Research, 3(4), 144-149. https://doi.org/10.70749/ijbr.v3i4.779